Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Trial for the treatment of acute myeloid leukaemia in children and adolescents
DRKS00022788Phase 3Terminated
- Sponsor
- German Society for Pediatric Oncology and Hematology
- Start
- Mar 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3 trial of clofarabine, daunorubicin, cytarabine and etoposide in acute myeloid leukemia (AML) (2 arms), sponsored by German Society for Pediatric Oncology and Hematology. Started Mar 2021; status: terminated.
02
Drugs
clofarabinedaunorubicincytarabineetoposide
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on DRKS00022788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00022788.